Comment on 'Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease'

Clin Exp Dermatol. 2023 Jul 21;48(8):930-931. doi: 10.1093/ced/llad118.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Crohn Disease* / complications
  • Crohn Disease* / drug therapy
  • Epidermolysis Bullosa Acquisita* / drug therapy
  • Humans
  • Ustekinumab / adverse effects

Substances

  • Ustekinumab